Cancer diagnostics giant Exact Sciences will close down its Baltimore operations three years after acquiring a company heralded as one of the region’s biggest success stories. Thrive Earlier Detection spun out of Johns Hopkins in 2019 and raised around $369 million in venture capital before Exact Sciences acquired it in a deal worth up to $2.15 billion. The Wisconsin-based firm now plans to close down Thrive’s Baltimore office at 1812 Ashland Ave. by March 31, 2024 and lay off 50 people.
Exact Sciences to close Baltimore office three years after $2.1B deal
January 31, 2024